Asaf Danziger, Chief Executive Officer at NovoCure Ltd (NVCR), sold 195,946 shares at $196.34 ($38.5M) on 2021-04-13, disclosed to the SEC on 2021-04-15.
Open-market sale of $38.5M NVCR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $196.34 | 97,973 | $19.2M | 50.0% |
| 2 | $196.34 | 97,973 | $19.2M | 50.0% |
| Total | $196.34 avg | 195,946 | $38.5M | 100% |
| Filing → |
| NVCR | SELL | 2020-12-22 | $61.4M | — | Filing → |
| NVCR | SELL | 2020-09-17 | $10.2M | — | Filing → |
| NVCR | SELL | 2019-11-26 | $9.8M | — | Filing → |